Johnson & Johnson Said To Reach Deal On Artificial Hip Suits

Johnson and Johnson is expected to pay out $2.5 billion to settle lawsuits over faulty artificial hips. The medical products maker will reportedly pay 8,000 U.S. patients $250,000 each for new hip replacement surgery.

Copyright © 2013 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

STEVE INSKEEP, HOST:

NPR's business news starts with a giant hip check.

(SOUNDBITE OF MUSIC)

INSKEEP: You know, sort of like you'd have in basketball or hockey. Johnson & Johnson has agreed to pay out $2.5 billion to settle a lawsuit over faulty artificial hips. The medical products maker will reportedly pay 8,000 American patients $250,000 each for new hip replacement surgery. An additional $475 million will cover other health problems caused by the faulty device which is called the articular service replacement or ASR.

Introduced in 2003, the ASR caused tissue damage and crippling injuries. Americans made up about one-third of the 93,000 people worldwide who had the faulty device implanted.

Copyright © 2013 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.